Suberoylanilide Hydroxamic Acid
Showing 26 - 50 of 8,024
Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma Trial in Seattle
Completed
- Chronic Lymphocytic Leukemia
- +8 more
- Fludarabine Phosphate
- +3 more
-
Seattle, Washington
- +1 more
Feb 14, 2020
Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, procedure, radiation, other)
Completed
- Male Breast Cancer
- +2 more
- vorinostat
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jan 2, 2020
Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)
Terminated
- Lymphoma
- Lenalidomide
- +12 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 26, 2019
Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in
Terminated
- Acute Lymphoblastic Leukemia
- +2 more
- Decitabine
- +6 more
-
Los Angeles, California
- +27 more
Oct 5, 2020
AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States
Completed
- AIDS-Related Plasmablastic Lymphoma
- +15 more
- Cyclophosphamide
- +8 more
-
Montgomery, Alabama
- +34 more
Feb 23, 2022
Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,
Completed
- Male Breast Cancer
- +2 more
- vorinostat
- +8 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019
Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
-
Hackensack, New JerseyHackensack University Medical Center
Oct 4, 2021
Myelodysplastic Syndrome Trial in France (Azacitidine and oral vorinostat)
Terminated
- Myelodysplastic Syndrome
- Azacitidine and oral vorinostat
-
Angers, France
- +23 more
May 24, 2019
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021
Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell
Completed
- Adult Diffuse Large B-Cell Lymphoma
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020
Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx Trial in Columbus (drug,
Completed
- Stage III Squamous Cell Carcinoma of the Oropharynx
- Stage IV Squamous Cell Carcinoma of the Oropharynx
- vorinostat
- +3 more
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Jun 3, 2019
Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston
Not yet recruiting
- Recurrent Aggressive Non-Hodgkin Lymphoma
- +6 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2020
Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States
Active, not recruiting
- Brain Stem Glioma
- +4 more
- Bevacizumab
- +2 more
-
Birmingham, Alabama
- +136 more
Oct 15, 2022
Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial
Active, not recruiting
- Ann Arbor Stage II Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +6 more
-
Mobile, Alabama
- +189 more
Jan 28, 2023
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- vorinostat
- +2 more
-
Stanford, California
- +3 more
May 2, 2019
HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)
Active, not recruiting
- HIV
- Combination Antiretroviral Therapy (cART)
- +4 more
-
Brighton, United Kingdom
- +5 more
Aug 24, 2021
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Recurrent NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in United States (vorinostat, laboratory biomarker analysis)
Completed
- Recurrent Non-small Cell Lung Cancer
- +2 more
- vorinostat
- laboratory biomarker analysis
-
Green Bay, Wisconsin
- +4 more
Jan 3, 2018
Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))
Completed
- Acute Myelogenous Leukemia
- Decitabine
- +4 more
-
Los Angeles, California
- +32 more
Jun 22, 2022
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1
Completed
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +6 more
- Laboratory Biomarker Analysis
- Vorinostat
-
Duarte, California
- +4 more
Feb 5, 2018